Fund Overview
ETF

Axis NIFTY Healthcare ETF

Ticker: AXISHCETFUnderlying Index: Nifty HealthcareISIN: INF846K01Z12

168.1512.96% (1Y)
End of Day NAV as on Sep 10, 2026
137147156166175Sep 2025Feb 2026Sep 2026

Fundamentals

Asset TypeEquity
Underlying Index TypeSectoral Index
No. of Companies20
Market Cap FocusLarge & Mid Cap
P/E53.97
P/B8.28
Div Yield0.50%
Down from 52w High11.50%
Up from 52w Low24.37%
Std Deviation (1 yr)0.84%

Fund Parameters

AUM (Cr)24
Base Expense Ratio0.33%
Tracking Error0.01%
All-In-Cost0.34%
Inception Date17 May 2021
Scheme Option - TypeGrowth - Open ended scheme
ETF Market Data
Latest Price168.13
NAV Gap-0.01%
1M Avg NAV Gap-0.06%
Daily Volume1,495
1M Avg Daily Volume5,498
1M Avg Daily Turnover0.1
Native Score

Similar Exchange Traded Funds (ETFs)

Swipe to view more data →

Fund NameLast CloseAUM (Cr)Avg Exp RatioTracking Error1M ADTO (Cr)1M Avg NAV GapAll-In-CostScore
169.472210.13%0.01%1-0.06%0.14%
17.00820.16%0.01%0-0.13%0.17%
16.66170.17%0.01%0N/A0.18%

Similar Index Funds

Swipe to view more data →

Fund NameLast CloseAUM (Cr)Avg Exp RatioTracking ErrorAll-In-CostScore
N/A220.21%0.04%0.25%

Sectoral Allocation

Total
100%
allocation
  • Healthcare99.2%
  • Business Services0.6%
  • Others0.1%
  • Finance0.0%

Fund Holdings

NameWeight
Sun Pharmaceutical Industries Ltd.18.3%
Divi's Laboratories Ltd.8.9%
Apollo Hospitals Enterprise Ltd.8.0%
Cipla Ltd.7.2%
Max Healthcare Institute Ltd.7.1%
Torrent Pharmaceuticals Ltd.6.5%
Laurus Labs Ltd.6.1%
Dr. Reddy's Laboratories Ltd.6.1%
Lupin Ltd.5.1%
Fortis Healthcare Ltd.4.3%
Aurobindo Pharma Ltd.3.8%
Alkem Laboratories Ltd.2.9%
Glenmark Pharmaceuticals Ltd.2.9%
Biocon Ltd.2.6%
Zydus Lifesciences Ltd.2.4%
Mankind Pharma Ltd.2.4%
Ipca Laboratories Ltd.2.1%
Abbott India Ltd.1.3%
Piramal Pharma Ltd.1.1%
Syngene International Ltd.0.6%
Net Current Asset0.1%
Clearing Corporation Of India Ltd.0.0%

Holdings Concentration

Total covered: 100%
Top 1–5
5 holdings
49.5%
50%
share
Top 6–10
5 holdings
28.1%
28%
share
Top 11–20
10 holdings
22.2%
22%
share
Beyond 20
2 holdings
0.1%
0%
share

Market Cap Classification

Total
100%
allocation
  • Mid Cap49.2%
  • Large Cap48.9%
  • Small Cap1.7%

Advanced Ratios

Alpha-0.00
Beta1.00
Sharpe Ratio0.05
Sortino Ratio0.09
Treynor Ratio0.04
Information Ratio-0.04
Upside Capture99.72%
Downside Capture99.85%

Index Methodology

Factor BasisSector/Theme
UniverseNifty 500
WeightagePeriodic Cappped Free-Float Market Cap Weighting, Max Weight per stock = 33%; Top 3 <62%
Stocks IncludedMaximum 20 companies. Top 20 stocks based on six-month average free-float market capitalization are selected
ExclusionsStocks Excluded from Nifty 500, Stocks not meeting criteria of top 20 based on Free Float market cap (Healthcare industry only)

Fund • Last updated: 11/09/2026